Should I buy or sell Rapid Micro Biosystems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rapid Micro Biosystems in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RPID shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RPID, but not buy additional shares or sell existing shares. View RPID analyst ratings or view top-rated stocks .

What is Rapid Micro Biosystems' stock price target for 2024?

1 analysts have issued 1 year price targets for Rapid Micro Biosystems' shares. Their RPID share price targets range from $2.75 to $2.75. On average, they predict the company's share price to reach $2.75 in the next year. This suggests a possible upside of 145.5% from the stock's current price. View analysts price targets for RPID or view top-rated stocks among Wall Street analysts .

How have RPID shares performed in 2023?

Rapid Micro Biosystems' stock was trading at $1.13 on January 1st, 2023. Since then, RPID shares have decreased by 0.9% and is now trading at $1.12. View the best growth stocks for 2023 here .

Are investors shorting Rapid Micro Biosystems?

Rapid Micro Biosystems saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 6,800 shares, a decrease of 16.0% from the October 31st total of 8,100 shares. Based on an average daily trading volume, of 23,900 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company's shares are short sold. View Rapid Micro Biosystems' Short Interest .

When is Rapid Micro Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 1st 2024. View our RPID earnings forecast .

How were Rapid Micro Biosystems' earnings last quarter?

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) posted its quarterly earnings data on Friday, November, 3rd. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.32) by $0.01. The company had revenue of $6.15 million for the quarter, compared to analyst estimates of $5.53 million. Rapid Micro Biosystems had a negative net margin of 280.90% and a negative trailing twelve-month return on equity of 39.55%. During the same quarter in the previous year, the company earned ($0.38) earnings per share.

When did Rapid Micro Biosystems IPO?

(RPID) raised $125 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share.

How do I buy shares of Rapid Micro Biosystems?

Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Rapid Micro Biosystems Stock Price, News & Analysis (NASDAQ:RPID)

$1.12

-0.01 (-0.88%)

(As of 12/8/2023 ET)

Compare

Today's Range: $1.12
▼
$1.14
50-Day Range: $0.97
▼
$1.17
52-Week Range: $0.83
▼
$1.89

Volume: 1,909 shs
Average Volume: 48,984 shs
Market Capitalization: $47.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.75

Rapid Micro Biosystems MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 145.5% Upside
$2.75 Price Target
Short Interest: Healthy
0.04% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.28) to ($1.15) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

220th out of 954 stocks

Medical Devices Industry

10th out of 31 stocks

3.0

Analyst's Opinion

Consensus Rating
Rapid Micro Biosystems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.75, Rapid Micro Biosystems has a forecasted upside of 145.5% from its current price of $1.12.
Amount of Analyst Coverage
Rapid Micro Biosystems has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.04% of the float of Rapid Micro Biosystems has been sold short.
Short Interest Ratio / Days to Cover
Rapid Micro Biosystems has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Rapid Micro Biosystems has recently decreased by 16.05%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Rapid Micro Biosystems does not currently pay a dividend.
Dividend Growth
Rapid Micro Biosystems does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RPID.

2.2

News and Social Media Coverage

News Sentiment
Rapid Micro Biosystems has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Rapid Micro Biosystems this week, compared to 1 article on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.
Percentage Held by Insiders
32.39% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
51.67% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($1.28) to ($1.15) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Rapid Micro Biosystems is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Rapid Micro Biosystems is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Rapid Micro Biosystems has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Rapid Micro Biosystems Stock (NASDAQ:RPID)

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

RPID Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RPID Stock News Headlines

December 4, 2023 | americanbankingnews.com

Short Interest in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Drops By 16.0%

November 7, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

December 8, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 5, 2023 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript

November 3, 2023 | msn.com

Rapid Micro Biosystems GAAP EPS of -$0.31, revenue of $6.1M

November 3, 2023 | finance.yahoo.com

Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results

November 3, 2023 | finance.yahoo.com

Rapid Micro Biosystems Inc (RPID) Reports 30% Revenue Growth in Q3 2023

October 19, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023

December 8, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

September 29, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4

September 19, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase

September 10, 2023 | finance.yahoo.com

Insider Buying: CFO Sean Wirtjes Acquires 10,000 Shares of Rapid Micro Biosystems Inc

September 6, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference

August 4, 2023 | finance.yahoo.com

Q2 2023 Rapid Micro Biosystems Inc Earnings Call

August 4, 2023 | finance.yahoo.com

Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results

August 4, 2023 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates

August 3, 2023 | benzinga.com

Rapid Micro Biosystems's Earnings Outlook

July 20, 2023 | finance.yahoo.com

Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023

July 19, 2023 | finanznachrichten.de

Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

July 18, 2023 | finance.yahoo.com

Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

July 5, 2023 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID) Moves to Buy: Rationale Behind the Upgrade

May 9, 2023 | finance.yahoo.com

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 6, 2023 | finance.yahoo.com

Q1 2023 Rapid Micro Biosystems Inc Earnings Call

May 5, 2023 | finanznachrichten.de

Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

May 5, 2023 | msn.com

Rapid Micro Biosystems: Q1 Earnings Insights

May 5, 2023 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates

May 5, 2023 | finance.yahoo.com

Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

See More Headlines

Receive RPID Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/03/2023
Today: 12/08/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/01/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:RPID
CUSIP: N/A
CIK: 1380106
Web: www.rapidmicrobio.com
Phone: 978-349-3200
Fax: N/A
Employees: 177
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $2.75
High Stock Price Target: $2.75
Low Stock Price Target: $2.75
Potential Upside/Downside: +145.5%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.35)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-60,810,000.00
Net Margins: -280.90%
Pretax Margin: -280.76%
Return on Equity: -39.55%
Return on Assets: -34.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.37
Quick Ratio: 6.07

Sales & Book Value

Annual Sales: $20.56 million
Price / Sales: 2.31
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.90 per share
Price / Book: 0.29

Miscellaneous

Outstanding Shares: 42,399,000
Free Float: 28,666,000
Market Cap: $47.49 million
Optionable: Not Optionable
Beta: 1.29

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Robert G. Spignesi Jr. (Age 53)
CEO, President & Director
Comp: $777.53k
Mr. Sean M. Wirtjes (Age 54)
Chief Financial Officer
Comp: $510.64k
Mr. John J. Addington Wilson (Age 55)
Chief Operating Officer
Comp: $512.94k
Michael Beaulieu C.F.A.
Vice President of Investor Relations & Corporate Communications
Mr. Michael Wysocki
Senior Vice President of Sales & Marketing
Ms. Victoria L. Vezina (Age 55)
Chief Human Resources Officer
Comp: $366.36k
Ms. Kristine Williams
Senior Vice President of Research & Development and Product Management

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

RPID Stock Analysis - Frequently Asked Questions

Should I buy or sell Rapid Micro Biosystems stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rapid Micro Biosystems in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RPID shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RPID, but not buy additional shares or sell existing shares.
View RPID analyst ratings or view top-rated stocks.
What is Rapid Micro Biosystems' stock price target for 2024?: 1 analysts have issued 1 year price targets for Rapid Micro Biosystems' shares. Their RPID share price targets range from $2.75 to $2.75. On average, they predict the company's share price to reach $2.75 in the next year. This suggests a possible upside of 145.5% from the stock's current price.
View analysts price targets for RPID or view top-rated stocks among Wall Street analysts.
How have RPID shares performed in 2023?: Rapid Micro Biosystems' stock was trading at $1.13 on January 1st, 2023. Since then, RPID shares have decreased by 0.9% and is now trading at $1.12.
View the best growth stocks for 2023 here.
Are investors shorting Rapid Micro Biosystems?: Rapid Micro Biosystems saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 6,800 shares, a decrease of 16.0% from the October 31st total of 8,100 shares. Based on an average daily trading volume, of 23,900 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company's shares are short sold.
View Rapid Micro Biosystems' Short Interest.

When is Rapid Micro Biosystems' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, March 1st 2024.
View our RPID earnings forecast.
How were Rapid Micro Biosystems' earnings last quarter?: Rapid Micro Biosystems, Inc. (NASDAQ:RPID) posted its quarterly earnings data on Friday, November, 3rd. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.32) by $0.01. The company had revenue of $6.15 million for the quarter, compared to analyst estimates of $5.53 million. Rapid Micro Biosystems had a negative net margin of 280.90% and a negative trailing twelve-month return on equity of 39.55%. During the same quarter in the previous year, the company earned ($0.38) earnings per share.
When did Rapid Micro Biosystems IPO?: (RPID) raised $125 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share.
How do I buy shares of Rapid Micro Biosystems?: Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:RPID) was last updated on 12/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rapid Micro Biosystems Stock Price, News & Analysis (NASDAQ:RPID)

Rapid Micro Biosystems MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Rapid Micro Biosystems Stock (NASDAQ:RPID)

RPID Stock Price History

RPID Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

RPID Stock Analysis - Frequently Asked Questions

Overall MarketRank^™